Ardent Health, Inc. (NYSE:ARDT) Given Consensus Recommendation of “Hold” by Analysts

Shares of Ardent Health, Inc. (NYSE:ARDT) have earned an average rating of “Hold” from the fourteen research firms that are currently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $14.2083.

A number of analysts have issued reports on ARDT shares. Wall Street Zen raised Ardent Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 16th. Royal Bank Of Canada dropped their target price on Ardent Health from $14.00 to $13.00 and set an “outperform” rating for the company in a report on Monday, March 9th. Zacks Research upgraded Ardent Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 25th. UBS Group lifted their target price on Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a report on Thursday, May 7th. Finally, Leerink Partners dropped their target price on Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a report on Friday, March 6th.

Hedge Funds Weigh In On Ardent Health

Institutional investors and hedge funds have recently modified their holdings of the stock. Denali Advisors LLC purchased a new position in shares of Ardent Health in the 3rd quarter worth approximately $2,449,000. Pier Capital LLC boosted its holdings in shares of Ardent Health by 33.5% in the 3rd quarter. Pier Capital LLC now owns 580,620 shares of the company’s stock worth $7,693,000 after purchasing an additional 145,703 shares during the period. Prescott Group Capital Management L.L.C. purchased a new position in shares of Ardent Health in the 4th quarter worth approximately $1,077,000. Vestcor Inc purchased a new position in shares of Ardent Health in the 4th quarter worth approximately $255,000. Finally, LSV Asset Management purchased a new position in shares of Ardent Health in the 4th quarter worth approximately $963,000.

Ardent Health Stock Performance

NYSE:ARDT opened at $9.17 on Friday. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.12 and a quick ratio of 2.00. Ardent Health has a 1 year low of $8.07 and a 1 year high of $15.48. The stock’s 50 day simple moving average is $9.38 and its two-hundred day simple moving average is $9.40. The company has a market cap of $1.31 billion, a price-to-earnings ratio of 9.65, a PEG ratio of 2.05 and a beta of 0.93.

Ardent Health (NYSE:ARDT) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.10. Ardent Health had a return on equity of 13.85% and a net margin of 2.09%.The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.58 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. As a group, equities analysts anticipate that Ardent Health will post 1.12 earnings per share for the current fiscal year.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.